InnovAge Holding Corp.
NASDAQ:INNVMedical - Care Facilities
-$0.01 today
- Market cap
- $1.22B
- Beta
- 0.45
- P/E (TTM)
- -55.8
- EPS (TTM)
- -$0.16
Volume 0.52M
Average 0.29M
INNV Operating Margin
Operating income as a percentage of revenue, showing the profitability of core operations.
InnovAge Holding Corp.NASDAQ: INNV
Operating Margin · Q3 FY2026 · quarter ended Mar 2026
Operating margin widens to 9.0%
Operating margin was 9.0% in Q3 FY2026, up 13.7 pp from a year earlier. On a trailing-twelve-month basis it was 3.9%, up 7.8 pp year over year. Over 3 fiscal years it narrowed by 2.9 pp.
Context
- Operating margin widened in 1 of the last 3 fiscal years.
What to watch
Whether operating margin reaches the consensus estimate from 3 analysts of 0.3% for the fiscal year ending Jun 2026, up from -3.5% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- 9.0%+2.3 pp QoQ
- Last fiscal yearJun 2025
- -3.5%-0.5 pp YoY
- LTMMar 2026
- 3.9%+7.8 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +13.7 pp | +11.0 pp | -2.7 pp |
| 1 year | -0.5 pp | +3.8 pp | +4.3 pp |
| 3 years | -2.9 pp | +12.0 pp | +14.8 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -3.5%
- Year-over-year change
- -0.5pp
| Period | Period end | Operating Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | -3.5% | -0.5pp |
| FY2024 | 2024-06-30 | -3.0% | +4.1pp |
| FY2023 | 2023-06-30 | -7.2% | -6.5pp |
| FY2022 | 2022-06-30 | -0.6% | -12.4pp |
| FY2021 | 2021-06-30 | 11.7% | — |
Operating Margin vs competitors
How INNV compares with its peers on the latest reported figures
- INNV's LTM Mar 2026 operating margin of 3.9% is the 7th highest of the 8 companies compared; the peer median is 8.5%.
- Its year-over-year change of +7.8 pp is the highest of 8, against a peer median of +0.9 pp.
- Over three fiscal years its change of -2.9 pp compares with a peer median of +2.5 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Oct 2026 | 11.8% | +1.6 pp | +46.8 pp | |
| LTM Jun 2026 | 10.0% | +0.9 pp | +2.5 pp | |
| LTM Sep 2026 | 9.8% | +1.7 pp | +5.5 pp | |
| LTM Jun 2026 | 8.5% | -0.0 pp | -1.4 pp | |
| LTM Sep 2026 | 7.1% | +7.4 pp | +2.1 pp | |
| LTM Mar 2026 | 5.7% | +0.0 pp | +2.7 pp | |
| LTM Mar 2026 | 3.9% | +7.8 pp | -2.9 pp | |
| LTM Mar 2026 | -20.5% | -16.1 pp | -3.0 pp | |
| Peer median (excluding INNV) | 8.5% | +0.9 pp | +2.5 pp | |
Competitors are the stored peer set for INNV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Revenue | 637.8M | 698.64M | 688.09M | 763.86M | 853.7M |
| Cost of Revenue | 476.01M | 563.27M | 586.8M | 631.79M | 268.91M |
| Gross Profit | 161.79M | 135.37M | 101.29M | 132.06M | 584.79M |
| Gross Margin | 25.4% | 19.4% | 14.7% | 17.3% | 68.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 154.57M | 125.85M | 135.26M | 136.29M | 150.28M |
| Operating Expenses | 86.96M | 139.78M | 150.68M | 155.24M | 614.55M |
| Depreciation & Amortization | 12.29M | 13.92M | 15.42M | 18.95M | 19.51M |
| EBITDA | (5.89M) | 9.21M | (33.85M) | 1.15M | 3.36M |
| EBITDA Margin | -0.9% | 1.3% | -4.9% | 0.2% | 0.4% |
| Operating Income | 74.82M | (4.41M) | (49.4M) | (23.18M) | (29.76M) |
| Operating Margin | 11.7% | -0.6% | -7.2% | -3.0% | -3.5% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 16.79M | 2.53M | 1.52M | 4.02M | 4.61M |
| Other Income / Expenses | (109.79M) | (2.83M) | (1.4M) | 1.36M | (4.27M) |
| Income Before Tax | (34.97M) | (7.24M) | (50.79M) | (21.82M) | (34.03M) |
| Pre-Tax Margin | -5.5% | -1.0% | -7.4% | -2.9% | -4.0% |
| Income Tax Expense | 9.77M | 723K | (7.24M) | 1.4M | 1.32M |
| Net Income | (43.99M) | (6.52M) | (40.67M) | (21.34M) | (30.31M) |
| Net Margin | -6.9% | -0.9% | -5.9% | -2.8% | -3.6% |
| EPS (Basic) | (0.33) | (0.05) | (0.30) | (0.16) | (0.22) |
| EPS (Diluted) | (0.33) | (0.05) | (0.30) | (0.16) | (0.22) |
| Weighted Avg Shares | 135.52M | 135.52M | 135.59M | 135.9M | 135.39M |
| Weighted Avg Shares (Diluted) | 135.52M | 135.52M | 135.59M | 135.9M | 135.39M |
InnovAge Holding Corp.
NASDAQ:INNV
Intrinsic Alpha fair value
Locked
Current Price
$8.91
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.